• レポートコード:QY20ST-07049 • 出版社/出版日:QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、139ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のリセドロネート市場について種類別(5mg錠、35mg錠、75mg錠、150mg錠)、用途別(閉経後骨粗しょう症、骨粗しょう症の男性)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リセドロネート市場の概要 ・世界の主要地域別リセドロネート市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリセドロネート市場規模2015-2026:種類別(5mg錠、35mg錠、75mg錠、150mg錠) ・世界のリセドロネート市場規模2015-2026:用途別(閉経後骨粗しょう症、骨粗しょう症の男性) ・リセドロネートの北米市場規模2015-2020 ・リセドロネートのヨーロッパ市場規模2015-2020 ・リセドロネートの中国市場規模2015-2020 ・リセドロネートの日本市場規模2015-2020 ・リセドロネートの東南アジア市場規模2015-2020 ・リセドロネートのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・リセドロネートの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リセドロネートの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Risedronate Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Risedronate market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget’s disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Risedronate market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Risedronate industry.
Based on our recent survey, we have several different scenarios about the Risedronate YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Risedronate will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Risedronate market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Risedronate market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Risedronate market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Risedronate market. The report also includes nautical information, where it shows Risedronate market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Risedronate market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Risedronate market.
Geographical Analysis:
Based on region, the global Risedronate market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Risedronate market are
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
Segment by Type
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Risedronate market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Risedronate market.
• The market share of the global Risedronate market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Risedronate market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Risedronate market.
1 Risedronate Market Overview
1.1 Risedronate Product Scope
1.2 Risedronate Segment by Type
1.2.1 Global Risedronate Sales by Type (2020-2026)
1.2.2 5 mg Tablets
1.2.3 35 mg Tablets
1.2.4 75 mg Tablets
1.2.5 150 mg Tablets
1.3 Risedronate Segment by Application
1.3.1 Global Risedronate Sales Comparison by Application (2020-2026)
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.4 Risedronate Market Estimates and Forecasts (2015-2026)
1.4.1 Global Risedronate Sales Growth Rate (2015-2026)
1.4.2 Global Risedronate Revenue and Growth Rate (2015-2026)
1.4.3 Global Risedronate Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Risedronate Industry Impact
1.5.1 How the Covid-19 is Affecting the Risedronate Industry
1.5.1.1 Risedronate Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Risedronate Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Risedronate Players to Combat Covid-19 Impact
2 Risedronate Estimate and Forecast by Region
2.1 Global Risedronate Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Risedronate Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Risedronate Sales Market Share by Region (2015-2020)
2.2.2 Global Risedronate Revenue Market Share by Region (2015-2020)
2.3 Global Risedronate Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Risedronate Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Risedronate Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Risedronate Estimates and Projections (2015-2026)
2.4.2 Europe Risedronate Estimates and Projections (2015-2026)
2.4.3 China Risedronate Estimates and Projections (2015-2026)
2.4.4 Japan Risedronate Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Risedronate Estimates and Projections (2015-2026)
2.4.6 India Risedronate Estimates and Projections (2015-2026)
3 Global Risedronate Competition Landscape by Players
3.1 Global Top Risedronate Players by Sales (2015-2020)
3.2 Global Top Risedronate Players by Revenue (2015-2020)
3.3 Global Risedronate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Risedronate as of 2019)
3.4 Global Risedronate Average Price by Company (2015-2020)
3.5 Manufacturers Risedronate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Risedronate Players (Opinion Leaders)
4 Global Risedronate Market Size by Type
4.1 Global Risedronate Historic Market Review by Type (2015-2020)
4.1.1 Global Risedronate Sales Market Share by Type (2015-2020)
4.1.2 Global Risedronate Revenue Market Share by Type (2015-2020)
4.1.3 Global Risedronate Price by Type (2014-2020)
4.2 Global Risedronate Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Risedronate Sales Forecast by Type (2021-2026)
4.2.2 Global Risedronate Revenue Forecast by Type (2021-2026)
4.2.3 Global Risedronate Price Forecast by Type (2021-2026)
5 Global Risedronate Market Size by Application
5.1 Global Risedronate Historic Market Review by Application (2015-2020)
5.1.1 Global Risedronate Sales Market Share by Application (2015-2020)
5.1.2 Global Risedronate Revenue Market Share by Application (2015-2020)
5.1.3 Global Risedronate Price by Application (2015-2020)
5.2 Global Risedronate Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Risedronate Sales Forecast by Application (2021-2026)
5.2.2 Global Risedronate Revenue Forecast by Application (2021-2026)
5.2.3 Global Risedronate Price Forecast by Application (2021-2026)
3 North America Risedronate Market Facts & Figures
3.2 North America Risedronate Sales Market Share by Company (2015-2020)
3.3 North America Risedronate Sales Market Share by Type (2015-2020)
3.4 North America Risedronate Sales Market Share by Application (2015-2020)
4 Europe Risedronate Market Facts & Figures
4.2 Europe Risedronate Sales Market Share by Company (2015-2020)
4.3 Europe Risedronate Sales Market Share by Type (2015-2020)
4.4 Europe Risedronate Sales Market Share by Application (2015-2020)
5 China Risedronate Market Facts & Figures
5.2 China Risedronate Sales Market Share by Company (2015-2020)
5.3 China Risedronate Sales Market Share by Type (2015-2020)
5.4 China Risedronate Sales Market Share by Application (2015-2020)
6 Japan Risedronate Market Facts & Figures
6.2 Japan Risedronate Sales Market Share by Company (2015-2020)
6.3 Japan Risedronate Sales Market Share by Type (2015-2020)
6.4 Japan Risedronate Sales Market Share by Application (2015-2020)
7 Southeast Asia Risedronate Market Facts & Figures
7.2 Southeast Asia Risedronate Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Risedronate Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Risedronate Sales Market Share by Application (2015-2020)
8 India Risedronate Market Facts & Figures
8.2 India Risedronate Sales Market Share by Company (2015-2020)
8.3 India Risedronate Sales Market Share by Type (2015-2020)
8.4 India Risedronate Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Risedronate Business
12.1 Merck
12.1.1 Merck Risedronate Corporation Information
12.1.2 Merck Risedronate Business Overview and Total Revenue
12.1.3 Merck Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Risedronate Products Offered
12.1.5 Merck Recent Development
12.2 Amgen
12.2.1 Amgen Risedronate Corporation Information
12.2.2 Amgen Risedronate Business Overview and Total Revenue
12.2.3 Amgen Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Risedronate Products Offered
12.2.5 Amgen Recent Development
12.3 Teva
12.3.1 Teva Risedronate Corporation Information
12.3.2 Teva Risedronate Business Overview and Total Revenue
12.3.3 Teva Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Risedronate Products Offered
12.3.5 Teva Recent Development
12.4 Mylan
12.4.1 Mylan Risedronate Corporation Information
12.4.2 Mylan Risedronate Business Overview and Total Revenue
12.4.3 Mylan Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Risedronate Products Offered
12.4.5 Mylan Recent Development
12.5 Apotex
12.5.1 Apotex Risedronate Corporation Information
12.5.2 Apotex Risedronate Business Overview and Total Revenue
12.5.3 Apotex Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Apotex Risedronate Products Offered
12.5.5 Apotex Recent Development
12.6 Sanofi
12.6.1 Sanofi Risedronate Corporation Information
12.6.2 Sanofi Risedronate Business Overview and Total Revenue
12.6.3 Sanofi Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Risedronate Products Offered
12.6.5 Sanofi Recent Development
12.7 Abbott
12.7.1 Abbott Risedronate Corporation Information
12.7.2 Abbott Risedronate Business Overview and Total Revenue
12.7.3 Abbott Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Risedronate Products Offered
12.7.5 Abbott Recent Development
12.8 Novartis
12.8.1 Novartis Risedronate Corporation Information
12.8.2 Novartis Risedronate Business Overview and Total Revenue
12.8.3 Novartis Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis Risedronate Products Offered
12.8.5 Novartis Recent Development
12.9 Tecoland
12.9.1 Tecoland Risedronate Corporation Information
12.9.2 Tecoland Risedronate Business Overview and Total Revenue
12.9.3 Tecoland Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Tecoland Risedronate Products Offered
12.9.5 Tecoland Recent Development
12.10 Taj Pharmaceuticals
12.10.1 Taj Pharmaceuticals Risedronate Corporation Information
12.10.2 Taj Pharmaceuticals Risedronate Business Overview and Total Revenue
12.10.3 Taj Pharmaceuticals Risedronate Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Taj Pharmaceuticals Risedronate Products Offered
12.10.5 Taj Pharmaceuticals Recent Development
13 Risedronate Manufacturing Cost Analysis
13.1 Risedronate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Risedronate
13.4 Risedronate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Risedronate Distributors List
14.3 Risedronate Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Risedronate Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Risedronate Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Risedronate Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Risedronate Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Risedronate Players to Combat Covid-19 Impact
Table 8. Global Market Risedronate Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Risedronate Sales (MT) by Region (2015-2020)
Table 10. Global Risedronate Sales Market Share by Region (2015-2020)
Table 11. Global Risedronate Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Risedronate Revenue Share by Region (2015-2020)
Table 13. Global Risedronate Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Risedronate Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Risedronate Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Risedronate Revenue Share Forecast by Region (2021-2026)
Table 17. Global Risedronate (MT) of Key Companies (2015-2020)
Table 18. Global Risedronate Sales Share by Company (2015-2020)
Table 19. Global Risedronate Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Risedronate Revenue Share by Company (2015-2020)
Table 21. Global Risedronate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Risedronate as of 2019)
Table 22. Global Risedronate Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Risedronate Manufacturing Sites and Area Served
Table 24. Manufacturers Risedronate Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Risedronate Players
Table 27. Global Risedronate Sales (MT) by Type (2015-2020)
Table 28. Global Risedronate Sales Share by Type (2015-2020)
Table 29. Global Risedronate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Risedronate Price (MT) by Type (2015-2020)
Table 31. Global Risedronate Sales Share by Type (2021-2026)
Table 32. Global Risedronate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Risedronate Revenue Share by Type (2021-2026)
Table 34. Global Risedronate Price (MT) by Type (2021-2026)
Table 35. Global Risedronate Sales (MT) by Application (2015-2020)
Table 36. Global Risedronate Sales Share by Application (2015-2020)
Table 37. Global Risedronate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Risedronate Price (MT) by Application (2015-2020)
Table 39. Global Risedronate Sales (MT) by Application (2021-2026)
Table 40. Global Risedronate Sales Share by Application (2021-2026)
Table 41. Global Risedronate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Risedronate Revenue Share by Application (2021-2026)
Table 43. Global Risedronate Price (MT) by Application (2021-2026)
Table 44. United States Risedronate Sales (MT) by Company (2015-2020)
Table 45. United States Risedronate Sales Market Share by Company (2015-2020)
Table 46. United States Risedronate Sales (MT) by Type (2015-2020)
Table 47. United States Risedronate Sales Market Share by Type (2015-2020)
Table 48. United States Risedronate Sales (MT) by Application (2015-2020)
Table 49. United States Risedronate Sales Market Share by Application (2015-2020)
Table 50. Europe Risedronate Sales (MT) by Company (2015-2020)
Table 51. Europe Risedronate Sales Market Share by Company (2015-2020)
Table 52. Europe Risedronate Sales (MT) by Type (2015-2020)
Table 53. Europe Risedronate Sales Market Share by Type (2015-2020)
Table 54. Europe Risedronate Sales (MT) by Application (2015-2020)
Table 55. Europe Risedronate Sales Market Share by Type (2015-2020)
Table 56. China Risedronate Sales (MT) by Company (2015-2020)
Table 57. China Risedronate Sales Market Share by Company (2015-2020)
Table 58. China Risedronate Sales (MT) by Type (2015-2020)
Table 59. China Risedronate Sales Market Share by Type (2015-2020)
Table 60. China Risedronate Sales (MT) by Application (2015-2020)
Table 61. China Risedronate Sales Market Share by Application (2015-2020)
Table 62. Japan Risedronate Sales (MT) by Company (2015-2020)
Table 63. Japan Risedronate Sales Market Share by Company (2015-2020)
Table 64. Japan Risedronate Sales (MT) by Type (2015-2020)
Table 65. Japan Risedronate Sales Market Share by Type (2015-2020)
Table 66. Japan Risedronate Sales (MT) by Application (2015-2020)
Table 67. Japan Risedronate Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Risedronate Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Risedronate Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Risedronate Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Risedronate Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Risedronate Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Risedronate Sales Market Share by Application (2015-2020)
Table 74. India Risedronate Sales (MT) by Company (2015-2020)
Table 75. India Risedronate Sales Market Share by Company (2015-2020)
Table 76. India Risedronate Sales (MT) by Type (2015-2020)
Table 77. India Risedronate Sales Market Share by Type (2015-2020)
Table 78. India Risedronate Sales (MT) by Application (2015-2020)
Table 79. India Risedronate Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Merck Risedronate Product
Table 84. Merck Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Amgen Risedronate Product
Table 89. Amgen Recent Development
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Teva Risedronate Product
Table 94. Teva Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Mylan Risedronate Product
Table 99. Mylan Recent Development
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Apotex Risedronate Product
Table 104. Apotex Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Sanofi Risedronate Product
Table 109. Sanofi Recent Development
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Abbott Risedronate Product
Table 114. Abbott Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Novartis Description and Business Overview
Table 118. Novartis Risedronate Product
Table 119. Novartis Recent Development
Table 120. Tecoland Corporation Information
Table 121. Tecoland Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Tecoland Description and Business Overview
Table 123. Tecoland Risedronate Product
Table 124. Tecoland Recent Development
Table . Taj Pharmaceuticals Corporation Information
Table . Taj Pharmaceuticals Description and Business Overview
Table . Taj Pharmaceuticals Risedronate Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Taj Pharmaceuticals Risedronate Product
Table . Taj Pharmaceuticals Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Risedronate Distributors List
Table 133. Risedronate Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Risedronate Product Picture
Figure 2. Global Risedronate Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Risedronate Market Share by Application in 2020 & 2026
Figure 6. Postmenopausal Osteoporosis Examples
Figure 7. Men with Osteoporosis Examples
Figure 8. Global Risedronate Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Risedronate Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Risedronate Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Risedronate Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Risedronate Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Risedronate Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Risedronate Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Risedronate Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Risedronate Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Risedronate Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Risedronate Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Risedronate Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Risedronate Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Risedronate Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Risedronate Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Risedronate Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Risedronate Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Risedronate Players Market Share by Revenue in Risedronate 2015 & 2019
Figure 26. Risedronate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Risedronate Revenue Share by Type (2015-2020)
Figure 28. Global Risedronate Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Risedronate Revenue Share by Application (2015-2020)
Figure 30. Global Risedronate Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Risedronate Sales Market Share by Type in 2019
Figure 32. United States Risedronate Sales Market Share by Type in 2019
Figure 33. Europe Risedronate Sales Market Share by Company in 2019
Figure 34. Europe Risedronate Sales Market Share by Type in 2019
Figure 35. Europe Risedronate Sales Market Share by Application in 2019
Figure 36. China Risedronate Sales Market Share by Company in 2019
Figure 37. China Risedronate Sales Market Share by Type in 2019
Figure 38. China Risedronate Sales Market Share by Application in 2019
Figure 39. Japan Risedronate Sales Market Share by Company in 2019
Figure 40. Japan Risedronate Sales Market Share by Type in 2019
Figure 41. Japan Risedronate Sales Market Share by Application in 2019
Figure 42. Southeast Asia Risedronate Sales Market Share by Company in 2019
Figure 43. Southeast Asia Risedronate Sales Market Share by Type in 2019
Figure 44. Southeast Asia Risedronate Sales Market Share by Application in 2019
Figure 45. India Risedronate Sales Market Share by Company in 2019
Figure 46. India Risedronate Sales Market Share by Type in 2019
Figure 47. India Risedronate Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Tecoland Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Risedronate
Figure 60. Manufacturing Process Analysis of Risedronate
Figure 61. Risedronate Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed